Compounds > ceratinamine
Page last updated: 2024-11-12

ceratinamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID10573320
CHEMBL ID478005
SCHEMBL ID4753065
MeSH IDM0542004

Synonyms (4)

Synonym
ceratinamine
CHEMBL478005
SCHEMBL4753065
n-[3-[4-(2-aminoethyl)-2,6-dibromophenoxy]propyl]-1-cyanoformamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID200942Tested for growth inhibition against human SF-268 CNS cancer cell line at 100 uM2002Bioorganic & medicinal chemistry letters, Mar-11, Volume: 12, Issue:5
Cytotoxic, antifouling bromotyramines: a synthetic study on simple marine natural products and Their analogues.
AID767736Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay2013Journal of natural products, Sep-27, Volume: 76, Issue:9
Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity.
AID767733Cytotoxicity against human MDA-MB-231 cells after 48 hrs by sulforhodamine B assay2013Journal of natural products, Sep-27, Volume: 76, Issue:9
Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity.
AID143033Tested for growth inhibition against human NCI-H460 lung cancer cell line at 100 uM2002Bioorganic & medicinal chemistry letters, Mar-11, Volume: 12, Issue:5
Cytotoxic, antifouling bromotyramines: a synthetic study on simple marine natural products and Their analogues.
AID103883Tested for growth inhibition against human MCF-7 breast cancer cell line at 100 uM2002Bioorganic & medicinal chemistry letters, Mar-11, Volume: 12, Issue:5
Cytotoxic, antifouling bromotyramines: a synthetic study on simple marine natural products and Their analogues.
AID767734Cytotoxicity against human ACHN cells after 48 hrs by sulforhodamine B assay2013Journal of natural products, Sep-27, Volume: 76, Issue:9
Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity.
AID767731Cytotoxicity against human NCI-H23 cells after 48 hrs by sulforhodamine B assay2013Journal of natural products, Sep-27, Volume: 76, Issue:9
Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity.
AID767732Cytotoxicity against human NUGC3 cells after 48 hrs by sulforhodamine B assay2013Journal of natural products, Sep-27, Volume: 76, Issue:9
Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity.
AID341034Cytotoxicity against human HCT116 cells at 10 ug/mL by MTT assay2008Journal of natural products, Aug, Volume: 71, Issue:8
Bioactive brominated metabolites from the Red Sea sponge Pseudoceratina arabica.
AID767735Cytotoxicity against human PC3 cells after 48 hrs by sulforhodamine B assay2013Journal of natural products, Sep-27, Volume: 76, Issue:9
Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity.
AID380813Induction of apoptosis in human U937 cells1999Journal of natural products, Jul, Volume: 62, Issue:7
7-Hydroxyceratinamine, a new cyanoformamide-containing metabolite from a sponge, Aplysinella sp.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.87 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
tyrosine
Tyrosine: A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin.. tyrosine : An alpha-amino acid that is phenylalanine bearing a hydroxy substituent at position 4 on the phenyl ring.		2.0810amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine		EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
oxazolidin-2-one
Oxazolidinones: Derivatives of oxazolidin-2-one. They represent an important class of synthetic antibiotic agents.. oxazolidin-2-one : An oxazolidinone that is 1,3-oxazolidine with an oxo substituent at position 2.. oxazolidinone : An oxazolidine containing one or more oxo groups.		2.0510carbamate ester;
oxazolidinone		metabolite
organophosphonates
hydrogenphosphite : A divalent inorganic anion resulting from the removal of a proton from two of the hydroxy groups of phosphorous acid.		2.0510divalent inorganic anion;
phosphite ion
psammaplysin a
psammaplysin A: cytotoxic psammaplysin analog from a Suberea sp. marine sponge; structure in first source		2.0410
psammaplysin f
psammaplysin F: isolated from sponge, Aplysinella sp.; structure given in first source		2.0810
ConditionIndicatedRelationship StrengthStudiesTrials